Advanced Search

 

Study ID Status Title Patient Level Data
Wellbutrin 25 Completed Multicenter Evaluation of the Efficacy and Safety of Bupropion vs. Placebo in Depressed Inpatients
WHP:86:34 Completed A preliminary study to investigate the safety, tolerability and pharmacokinetics of intranasally administered GR43175N in 6 healthy male volunteers.
WHP:86:38 Completed GR43175 base plasma levels after single oral doses (dispersible tablets) of 70mg, 140mg and 280mg GR43175 base (as succinate) in 6 healthy volunteers.
WHP:87:12, WHP:88:12 Completed Radioisotope Study To Investigate The Metabolic Disposition Of GR38032 In Man
WHP:88:03 Completed To Investigate the Effect of Regular Treatment With Salmeterol on the Cardiovascular, Tremorogenic, Metabolic, and Respiratory Effects of Inhaled Salbutamol (Study No. WHP:88:03)
WHP:88:13 Completed Metabolic Studies on Salmeterol Hydroxynaphthoate. The Absorption, Metabolism and Excretion of 14C-Salmeterol in Man After Oral Administration of 14C-Salmeterol Hydroxynaphthoate (1mg Base)
WHP:88:15 Completed The Effect of Regular Treatment with Salmeterol on the Cardiovascular System, 12-Lead ECG, Skeletal Muscle Tremor and Lung Function
WHP:88:16 Completed The effect of two consecutive doses of GR43175N, administered as an intranasal spray, on peak plasma drug levels
WHP:88:20 Completed To determine the effect of food on the pharmacokinetics of oral GR43175C
WHP:88:34 Completed To examine the pharmacokinetics, safety and tolerability of repeat oral dosing with GR43175C.
WHP:88:35 Completed The safety, tolerability and pharmacokinetics of two oral doses of GR43175C separated by two hours.
WHP:88:81 Completed To determine whether propranolol has any effect on the pharmacokinetics or pharmacodynamics of oral G43175C in healthy subjects.
WHP:88:82 Completed A pilot study to evaluate the effect of GR43175C on gastric emptying in healthy subjects.
WHP:88:83 Completed A study to investigate any interaction between pizotifen and GR43175C.
WHP:88:84 Completed A study to determine whether flunarizine has any effect on the pharmacokinetics and pharmacodynamics of oral G43175C in healthy subjects
WHP:89:08 Completed A study to investigate the tolerance of subcutaneous injection with GR43175C at concentrations of 12, 16 and 24 mg/mL.
WHP:89:10 Completed A study to investigate the pharmacokinetics of GR43175C after four different oral doses.
WHP:89:11 Completed A study to determine whether alcohol has any effect on the pharmacokinetics or pharmacodynamics of GR43175C administered orally.
WHP:89:12 Completed An assessment of the pharmacokinetics and local site irritancy after subcutaneous administration of GR43175C using a standard subcutaneous injection technique and an autoinjector.
WHP:89:18 Completed An investigation into the effects of single oral doses of GR43175C on psychomotor function in healthy subjects.
WHP:89:19 Completed A pilot study to investigate safety and tolerability of subcutaneously administered GR43175C in the elderly.
WHP:89:21 Completed An Investigation Into the Effect of Regular Dosing With Inhaled Salmeterol on the Non-Pulmonary Effects of a Cumulative Dose of Salmeterol. Protocol Number (WHP:89:21).
WHP:89:26 Completed A Study Of The Cardiovascular Effects Of Intravenous GR38032F 16 Mg In Healthy Volunteers
WHP:89:30 Completed A study to monitor blood pressure after administration of oral GR43175C in young and elderly subjects.
WHP8625 Completed A preliminary study to investigate the safety, tolerability and pharmacokinetics of intramuscularly administered GR43175C in three healthy male volunteers.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.